Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 246-677-8 | CAS number: 25155-23-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- September 29 1982 to January 25 1983
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Non GLP, carried out according to recognised (older) guideline, results fully documented. Considered appropriate for use based on data available and animal welfare concerns.
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 984
- Report date:
- 1984
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: Consistent with Environmental Protection Agency's Guidelines for registering pesticides in the U.S.: Hazard evaluation: Humans and Domestic Animals, Fed. Reg. 43:163 37336-37402 (1978). and OECD Guidelines (1981)
- Deviations:
- no
- Principles of method if other than guideline:
- Sprague-Dawley albino rats were used for test purposes. The test material was either dissolved or suspended in a suitable vehicle. The test material was administered in single doses by means of the gavage tube. A minimum of ten animals were used for each dose level. The animals were fasted for 16-18 hours prior to treatment. The animals were observed for at least 14 days after treatment for mortality and signs of toxicity. Necropsies were performed on all animals that died during the study (with the exception of cannabalized animals) and on all survivors.
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- Trixylenyl phosphate
- IUPAC Name:
- Trixylenyl phosphate
- Reference substance name:
- Fyrquel EHC
- IUPAC Name:
- Fyrquel EHC
- Details on test material:
- - Name of test material (as cited in study report): Fyrquel EHC (Trixylenyl phosphate)
- Molecular formula (if other than submission substance): not applicable
- Molecular weight (if other than submission substance): not applicable
- Smiles notation (if other than submission substance): not applicable
- InChl (if other than submission substance): not applicable
- Structural formula attached as image file (if other than submission substance): not applicable
- Substance type: not specified
- Physical state: liquid
- Analytical purity: not specified
- Impurities (identity and concentrations): not specified
- Composition of test material, percentage of components: not specified
- Isomers composition: not specified
- Purity test date: not specified
- Lot/batch No.: #9221-J-1-1X
- Expiration date of the lot/batch: not specified
- Radiochemical purity (if radiolabelling): not applicable
- Specific activity (if radiolabelling): not applicable
- Locations of the label (if radiolabelling): not applicable
- Expiration date of radiochemical substance (if radiolabelling): not applicable
- Stability under test conditions: not specified
- Storage condition of test material: not specified
- Other:
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Animals used in this study were purchased from Charles River laboratories, Portage, Michigan. No details on environmental conditions are provided.
Males, Weight Range, grams: 182-214
Females, Weight Range, grams: 142-179
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- The test material was administered in single doses by means of the gavage tube. A minimum of ten animals were used for each dose level. The animals were fasted for 16-18 hours prior to treatment.
- Doses:
- 5000 mg/kg
- No. of animals per sex per dose:
- 10
- Control animals:
- yes
- Details on study design:
- Sprague-Dawley albino rats were used for test purposes. The test material was either dissolved or suspended in a suitable vehicle. The test material was administered in single doses by means of the gavage tube. A minimum of ten animals were used for each dose level. The animals were fasted for 16-18 hours prior to treatment. The animals were observed for at least 14 days after treatment for mortality and signs of toxicity. Necropsies were performed on all animals that died during the study (with the exception of cannabalized animals) and on all survivors.
- Statistics:
- None reported.
Results and discussion
- Preliminary study:
- Not applicable.
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Mortality:
- 0/10 per sex
- Clinical signs:
- other: Males: A single dose of 5000 mg/kg produced no mortalities. Adverse clinical signs for all rats included mild depression, piloerection, wet fur, diarrhea, yellowish anogenital stains, evidence of excessive urination, and red facial stains. All rats a
- Gross pathology:
- All rats were necropsied following termination on Day 14 and appeared normal.
- Other findings:
- None
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The acute oral LD50 for Fyrquel EHC (Trixylenyl Phosphate) given to male albino rats was >5000 mg/kg. Commonly observed adverse clinical signs included depression, piloerection, wet fur, diarrhea, yellow anogenital stains, evidence of excessive urination, and red facial stains. All rats
appeared normal at necropsy.
The acute oral LD50 for Fyrquel EHC (Trixylenyl Phosphate) given to female albino rats was >5000 mg/kg. Commonly observed adverse clinical signs included depressions piloerection, ataxia, evidence of excessive urination, and red-stained muzzles. All rats appeared normal at necropsy. - Executive summary:
The acute oral LD50 for male and female albino rats was > 5000 mg/kg body weight. Commonly observed adverse clinical signs included: Mild to moderate depression, piloerection, ataxia (female rats only), wet fur (male rats only), diarrhea (male rats only), yellowish anogenital stains (male rats only), evidence of excessive urination and red facial stains. All rats appeared normal at necropsy.
The substance is not classified on the basis of the results.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
